Skip to main content

Table 5 Adjusted association between fasting blood glucose and glycated albumin in those with confirmed type 2 diabetes

From: The agreement between fasting glucose and markers of chronic glycaemic exposure in individuals with and without chronic kidney disease: a cross-sectional study

 

MODEL 1

MODEL 2

MODEL 3

β

95% CI

p

β

95% CI

p

β

95% CI

p

Glycated albumin

0.40

0.35 to 0.44

< 0.0001

0.41

0.36 to 0.45

< 0.0001

0.38

0.31 to 0.45

< 0.0001

Age

−0.05

− 0.08 to − 0.02

0.005

− 0.05

−0.08 to − 0.01

0.006

−0.07

− 0.12 to − 0.02

0.009

Gender

− 0.51

−1.47 to 0.44

0.291

− 0.23

− 1.18 to 0.72

0.635

0.04

− 1.33 to 1.42

0.950

CKD

−1.57

−4.52 to 1.38

0.296

−1.66

−4.54 to 1.23

0.260

−1.79

−4.78 to 3.19

0.695

CKDxGA

0.09

−0.05 to 0.22

0.215

0.09

−0.04 to 0.23

0.169

0.06

−0.10 to 0.23

0.448

BMI

0.07

0.02 to 0.13

0.005

Serum albumin

−0.21

−0.39 to − 0.02

0.027

Adjusted R2

0.62

0.64

0.59

  1. Data represents β-coefficients, 95% confidence interval, p-value and adjusted-R2. BMI, body mass index; CKD, chronic kidney disease; GA, glycated albumin; CKDxGA, interaction between CKD and GA. Model 1: GA + age + gender + CKD + CKDxGA; Model 2: Model 1 + BMI. Model 3: Model 1 + serum albumin